Akeso Biopharma

Podcast
The Top Line
Podcast

ESMO, WCLC lung cancer data spark hope—and debate

In this week's "The Top Line," Fierce journalists discuss key issues from promising but debated lung cancer data at recent conferences.
Asia

Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia

Sep 13, 2024 8:53am
boxing punch blow hit punching bag fight

Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study

Sep 8, 2024 11:30am
ASCO

Daiichi, Akeso, Genscript and Legend— Fierce Pharma Asia

Jun 7, 2024 6:00am
head-to-head faceoff competition

Summit and Akeso deliver Keytruda-topping results in NSCLC

May 31, 2024 11:00am
Asia

AstraZeneca, Takeda, BioNTech—Fierce Pharma Asia

Nov 10, 2023 8:05am